03-29497. Memorandum of Understanding Between the Food and Drug Administration and the Centers for Disease Control  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration (FDA) and the Centers for Disease Control. The purpose of the MOU is to provide a framework for coordination and cooperation between the two agencies and to provide the principles and procedures by which information exchanges shall take place.

    DATES:

    The agreement became effective June 19, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ellen F. Morrison, Emergency Operations Center (HFC-160), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5660.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature
    Start Printed Page 66451

    Dated: November 13, 2003.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 66452

    Start Printed Page 66453

    Start Printed Page 66454

    Start Printed Page 66455

    Start Printed Page 66456

    Start Printed Page 66457

    Start Printed Page 66458

    Start Printed Page 66459

    Start Printed Page 66460

    Start Printed Page 66461

    End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. 03-29497 Filed 11-25-03; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
6/19/2003
Published:
11/26/2003
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
03-29497
Dates:
The agreement became effective June 19, 2003.
Pages:
66450-66461 (12 pages)
Docket Numbers:
FDA 225-03-8001
PDF File:
03-29497.pdf